Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)

Stopped Poor accrual, changes in management of newly diagnosed myeloma patients, new drugs/more effective regimens.

Conditions

• Multiple Myeloma

Interventions

• DRUG: zoledronic acid
• DRUG: dexamethasone
• DRUG: thalidomide
• DRUG: vincristine
• DRUG: adriamycin

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

• [object Object]